• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Zomedica Pharmaceuticals Corp (NY: ZOM )

    0.1372 +0.0047 (+3.55%)
    Streaming Delayed Price Updated: 1:31 PM EDT, Sep 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Zomedica Pharmaceuticals Corp

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Good morning! It's time for a breakdown of the biggest pre-market stock movers for Tuesday and the news that has them moving. 
    Via InvestorPlace
    Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors
    Via ACCESSWIRE
    Here's What's Going On With Zomedica Shares
    Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 13.9% to $0.32 Tuesday morning after the company reported second-quarter earnings results. What Happened? 
    Via Benzinga
    Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined Revenues
    Via ACCESSWIRE
    Zomedica Corp. (NYSE American: ZOM) Featured in Coverage of Investor Summit Group’s Q3 Virtual Event
    Via Investor Brand Network
    ZOM Stock Pops 5% as Zomedica Acquires Revo Squared
    ZOM stock is on the rise as Zomedica acquires crucial technology that will provide veterinarians with enhanced diagnostic imaging quality. 
    Via InvestorPlace
    This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
    Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids. 
    Via Benzinga
    Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session
    Gainers GreenBox POS (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales. 
    Via Benzinga
    Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health
    ANN ARBOR, MI / ACCESSWIRE / July 18, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
    From Zomedica Corp.
    Via AccessWire
    Zomedica Announces New Global Manufacturing & Distribution Center
    ANN ARBOR, MI / ACCESSWIRE / July 7, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
    From Zomedica Corp.
    Via AccessWire
    Coinbase, Moderna And 56 Biggest Movers From Yesterday
    Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time... 
    Via Benzinga
    Why Is SCWorx (WORX) Stock Up 37% Today?
    SCWorx (WORX) stock is rocketing higher on Wednesday after boosting investor confidence with a stock purchase agreement! 
    Via InvestorPlace
    Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared
    ANN ARBOR, MI / ACCESSWIRE / July 6, 2022 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary health company offering diagnostic and therapeutic products for companion... 
    From Zomedica Corp.
    Via AccessWire
    Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team
    ANN ARBOR, MI / ACCESSWIRE / June 28, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and... 
    From Zomedica Corp.
    Via AccessWire
    Topics Supply Chain
    Exposures Supply Chain
    Zomedica to Participate in Panel Discussion at Animal Health Investment Forum
    ANN ARBOR, MI / ACCESSWIRE / June 21, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
    From Zomedica Corp.
    Via AccessWire
    Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared
    ANN ARBOR, MI / ACCESSWIRE / June 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
    From Zomedica Corp.
    Via AccessWire
    Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses
    ANN ARBOR, MI / ACCESSWIRE / June 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
    From Zomedica Corp.
    Via AccessWire
    Topics Law Enforcement
    Exposures Legal
    Zomedica to Present at JMP Securities Life Sciences Conference
    ANN ARBOR, MI / ACCESSWIRE / June 8, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for... 
    From Zomedica Corp.
    Via AccessWire
    Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary
    ANN ARBOR, MI / ACCESSWIRE / June 2, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for... 
    From Zomedica Corp.
    Via AccessWire
    Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line
    ANN ARBOR, MI / ACCESSWIRE / May 19, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
    From Zomedica Corp.
    Via AccessWire
    Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp.
    NEW YORK, NY / ACCESSWIRE / May 18, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a... 
    From Traders News Source
    Via AccessWire
    Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans
    ANN ARBOR, MI / ACCESSWIRE / May 16, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for... 
    From Zomedica Corp.
    Via AccessWire
    Why Zomedica Shares Are Falling Today
    Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 4.99% at $0.20. The company reported first-quarter earnings results during Tuesday’s after-hours session. Zomedica reported a first-quarter EPS... 
    Via Benzinga
    Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues
    ANN ARBOR, MI / ACCESSWIRE / May 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for... 
    From Zomedica Corp.
    Via AccessWire
    Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship
    Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
    From Zomedica Corp.
    Via AccessWire
    Stocks That Hit 52-Week Lows On Thursday
    During Thursday, 849 stocks hit new 52-week lows. 
    Via Benzinga
    Earnings Scheduled For May 10, 2022
    Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    Wednesday's session saw 784 companies set new 52-week lows. 
    Via Benzinga
    Continue to Steer Clear of MULN Stock
    Small-cap, battleground EV play MULN stock could deliver a blow to bears, but for today investors should simply avoid a poor investment. 
    Via InvestorPlace
    Zomedica to Present at H.C. Wainwright Global Investment Conference
    ANN ARBOR, MI / ACCESSWIRE / April 27, 2022 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals,... 
    From Zomedica Corp.
    Via AccessWire
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.